chr15-40471262-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_130468.4(CHST14):c.49C>T(p.Pro17Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000268 in 1,492,320 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_130468.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHST14 | NM_130468.4 | c.49C>T | p.Pro17Ser | missense_variant | 1/1 | ENST00000306243.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHST14 | ENST00000306243.7 | c.49C>T | p.Pro17Ser | missense_variant | 1/1 | NM_130468.4 | P1 | ||
CHST14 | ENST00000559991.1 | c.49C>T | p.Pro17Ser | missense_variant | 1/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152012Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000109 AC: 1AN: 91870Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 52276
GnomAD4 exome AF: 0.00000149 AC: 2AN: 1340308Hom.: 0 Cov.: 32 AF XY: 0.00000151 AC XY: 1AN XY: 661090
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152012Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74260
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 03, 2022 | The p.P17S variant (also known as c.49C>T), located in coding exon 1 of the CHST14 gene, results from a C to T substitution at nucleotide position 49. The proline at codon 17 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at